BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38839720)

  • 1. Effect of mPEG-PLGA on Drug Crystallinity and Release of Long-Acting Injection Microspheres: In Vitro and In Vivo Perspectives.
    Xing D; Tang L; Yang H; Yan M; Yuan P; Wu Y; Zhang Y; Yin T; Wang Y; Gou J; Tang X; He H
    Pharm Res; 2024 Jun; 41(6):1271-1284. PubMed ID: 38839720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
    Guo Y; Yang Y; He L; Sun R; Pu C; Xie B; He H; Zhang Y; Yin T; Wang Y; Tang X
    Pharm Res; 2017 Oct; 34(10):2211-2222. PubMed ID: 28741064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro-In Vivo Relationship of Amorphous Insoluble API (Progesterone) in PLGA Microspheres.
    Pu C; Wang Q; Zhang H; Gou J; Guo Y; Tan X; Xie B; Yin N; He H; Zhang Y; Wang Y; Yin T; Tang X
    Pharm Res; 2017 Dec; 34(12):2787-2797. PubMed ID: 28948463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.
    Xie B; Liu Y; Guo Y; Zhang E; Pu C; He H; Yin T; Tang X
    Pharm Res; 2018 Feb; 35(3):62. PubMed ID: 29445971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
    Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merits of sponge-like PLGA microspheres as long-acting injectables of hydrophobic drug.
    Kim S; Sah H
    J Biomater Sci Polym Ed; 2019 Dec; 30(18):1725-1743. PubMed ID: 31443621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of mPEG proportion and LA/GA ratio on degradation and drug release behaviors of PLGA-mPEG microparticles.
    Shi C; Liu P; Liu X; Feng X; Fu D
    Pharmazie; 2016 May; 71(5):243-6. PubMed ID: 27348966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry fabrication of poly(dl-lactide-co-glycolide) microspheres incorporating a medium molecular drug by a ball mill method.
    Matsumoto A; Murakami M
    Drug Discov Ther; 2021 Mar; 15(1):20-27. PubMed ID: 33627576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
    Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ
    Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends.
    Wang T; Xue P; Wang A; Yin M; Han J; Tang S; Liang R
    Eur J Pharm Sci; 2019 Oct; 138():104990. PubMed ID: 31302216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
    Katsikogianni G; Avgoustakis K
    J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats].
    Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N
    Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered PLGA microspheres for extended release of brexpiprazole:
    Wu B; Wu L; He Y; Yin Z; Deng L
    Drug Dev Ind Pharm; 2021 Jun; 47(6):1001-1010. PubMed ID: 34032181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and In Vivo Evaluation of Sustained Release Microparticles Loaded with Levothyroxine for Hypothyroidism Treatment.
    Alhawari HH; Abuhamdan RM; Alrashdan M; Al Thaher Y; Shraideh ZA; Abulateefeh SR
    J Pharm Sci; 2024 Jun; 113(6):1566-1571. PubMed ID: 38232803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
    Erdemli Ö; Özen S; Keskin D; Usanmaz A; Batu ED; Atilla B; Tezcaner A
    J Biomater Appl; 2014 Oct; 29(4):524-42. PubMed ID: 24854983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
    Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation.
    Wang W; Cai Y; Zhang G; Liu Y; Sui H; Park K; Wang H
    Drug Deliv; 2016 Nov; 23(9):3674-3680. PubMed ID: 27689622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entecavir-loaded poly (lactic-co-glycolic acid) microspheres for long-term therapy of chronic hepatitis-B: Preparation and in vitro and in vivo evaluation.
    Zhang C; Wang A; Wang H; Yan M; Liang R; He X; Fu F; Mu H; Sun K
    Int J Pharm; 2019 Apr; 560():27-34. PubMed ID: 30711615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.